Naval Daver, MD¹, Pau Montesinos, PhD, MD^2*, Jessica K. Altman, MD³, Eunice S. Wang, MD⁴, Giovanni Martinelli, MD⁵, Gail J. Roboz, MD⁶, Kebede Begna, MD⁷, Paresh Vyas, FMedSci, DPhil, FRCPath^8*, Monia Lunghi, MD, PhD^9*, Uwe Platzbecker, MD¹⁰, Patrick W. Burke, MD¹¹, Roland B. Walter, MD, PhD, MS¹², Anjali S. Advani, MD¹³, Sylvain Garciaz^14*, Lauris Gastaud^15*, David A Sallman, MD¹⁶, Naveen Pemmaraju, MD¹, Laura Torres, MD^2*, Yasmin Abaza, MD³, Onyee Chan, MD^16*, Hagop M. Kantarjian, MD¹, Benjamin Oshrine, MD^17*, Yining Du, PhD^17*, Kara Malcolm, RN^17* and Kendra Sweet, MD¹⁶

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hospital Universitari i Politècnic La Fe, Valencia, Spain
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁴Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁵IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST S.r.l., Meldola, Italy
⁶Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
⁹Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
¹⁰Department of Hematology, Cell Hematology and Hemostaseology, Leipzig University Hospital, Leipzig, Germany
¹¹University of Michigan, Ann Arbor, MI
¹²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
¹⁴Hematology Department, Integrative Structural and Chemical Biology, Aix-Marseille Université, Inserm, CNRS, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
¹⁵Centre Antoine Lacassagne, Tourrettes-sur-Loup, France
¹⁶H. Lee Moffitt Cancer Center, Tampa, FL
¹⁷ImmunoGen, Inc., Waltham, MA

Ibrahim Aldoss, MD¹, Ghayas C. Issa², Michael Thirman³, John DiPersio⁴, Martha Arellano⁵, James S. Blachly⁶, Gabriel N. Mannis⁷, Alexander Perl⁸, David S. Dickens^9*, Christine M. McMahon¹⁰, Elie Traer, MD, PhD¹¹, C. Michel Zwaan, MD^12,13*, Carolyn Grove¹⁴, Richard Stone¹⁵, Paul J Shami^16*, Ioannis Mantzaris¹⁷, Matthew Greenwood¹⁸, Neerav Shukla¹⁹, Branko Cuglievan², Yu Gu^20*, Rebecca G. Bagley^20*, Kate Madigan^20*, Soujanya Sunkaraneni^20*, Huy Van Nguyen^20*, Nicole McNeer^20* and Eytan M. Stein¹⁹

¹City of Hope National Medical Center, Duarte, CA
²The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Chicago Medicine, Chicago, IL
⁴Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁵Emory University School of Medicine, Atlanta, GA
⁶The Ohio State University, Columbus, OH
⁷Stanford University School of Medicine, Stanford, CA
⁸University of Pennsylvania, Philadelphia, PA
⁹University of Iowa Stead Family Children's Hospital, Iowa City, IA
¹⁰University of Colorado School of Medicine, Aurora, CO
¹¹Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR
¹²Princess Máxima Center, Utrecht, Netherlands
¹³Erasmus University Medical Center, Rotterdam, Netherlands
¹⁴Sir Charles Gairdner Hospital, Crawley, Australia
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
¹⁷Montefiore Einstein Cancer Center, Bronx, NY
¹⁸Royal North Shore Hospital, St Leonards, Australia
¹⁹Memorial Sloan Kettering Cancer Center, New York, NY
²⁰Syndax Pharmaceuticals, Inc., Waltham, MA

Junyuan Qi, MD^1*, Lin Song, MD^2*, Xudong Wei^3*, Zhimin Zhai, MD⁴, Anyou Wang, MD^5*, Daozi Jiang, MD^6*, Yang Liang, MD^7*, Fei Li^8*, Zhongxing Jiang, MD^9*, Xuejun Zhang, MD^10*, Qunyi Guo^11*, Hongmei Jing, MD¹², Yajing Xu, MD^13*, Xiangmin Tong, MD^14* and Jianxiang Wang, MD¹⁵

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematologic Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
²Institute of Hematology, Blood Disease Hospital, Chinese Academy of Medical Sciences, Pekiing Union College, Tianjin, China
³Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁴The Second Affiliated Hospital of Anhui Medical University, Hefei, China
⁵Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
⁶Department of Hematology, Hubei Provincial People's Hospital, Wuhan, China
⁷Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
⁸The First Affiliated Hospital of Nanchang University, Nanchang, China
⁹Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹⁰Department of Hematology, The Second Hospital of Hebei Medical University,, Shijiazhuang, China
¹¹Department of Hematology, Taizhou Hospital of Zhejiang Province, Wenzhou Medical College, Taizhou, China
¹²Peking University Third Hospital, Beijing, China
¹³Department of Hematoogy, Xiangya Hospital, Central South University, Changsha, China
¹⁴Department of Hematology, Hangzhou First People's Hospital, Hangzhou, Chile
¹⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Alexandre Bazinet, MD^1*, Hagop M. Kantarjian, MD², Farhad Ravandi, MD, MBBS³, Nicholas J. Short, MD⁴, Naval Daver, MD⁴, Maro Ohanian, DO^4*, Musa Yilmaz, MD^4*, Kelly S. Chien, MD⁴, Abhishek Maiti, MD¹, Courtney D. DiNardo, MD, MSc⁴, Jo Ishizawa, MD, PhD⁵, Lucia Masarova, MD⁴, Debra Bull-Linderman, RN^1*, Gautam Borthakur, MD⁴, Elias Jabbour⁶, Guillermo Garcia-Manero, MD⁷ and Tapan M. Kadia, MD⁴

¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
²Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas- MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁷University of Texas MD Anderson Cancer Center, Houston, TX

Robert Briski, MD^*, Nicholas J. Short, MD, Naval Daver, MD, Tapan M. Kadia, MD, Courtney D. DiNardo, MD, MSc, Musa Yilmaz, MD^*, Yesid Alvarado Valero, MD, Kenneth Vaughan^*, Sherry Pierce, BSN, BA^*, Kathryn Montalbano^*, Jillian Mullin, BA, RN, MN^*, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD and Farhad Ravandi, MD, MBBS

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Naval Daver, MD¹, Joshua F. Zeidner, MD², Junichiro Yuda, MD, PhD³, Justin M. Watts, MD⁴, Mark J. Levis, MD, PhD⁵, Kentaro Fukushima, MD, PhD^6*, Takayuki Ikezoe, MD, PhD⁷, Yoshiaki Ogawa, MD, PhD^8*, Joseph Brandwein, MD⁹, Eunice S. Wang, MD¹⁰, Yasushi Miyazaki, MD PhD¹¹, Timothy S Pardee, MD, PhD¹², Naoko Hosono, MD¹³, Takahiro Shima, MD, PhD¹⁴, Hisayuki Yokoyama^15*, Noboru Asada, MD, PhD¹⁶, Joseph Jurcic, MD¹⁷, Hongliang Cai, PhD^18*, Akinobu Watanabe^18*, Matthew Hitron, MD^18*, Emily Brooks, PhD^18*, Bo Xu, PhD^18*, Jatin Shah, MD^18*, Hagop M. Kantarjian, MD¹ and Harry P. Erba, MD, PhD¹⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
³National Cancer Center Hospital East, Kashiwa, Japan
⁴Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, MIAMI, FL
⁵Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
⁶Osaka University Graduate School of Medicine, Suita, Japan
⁷Fukushima Medical University, Fukushima, Japan
⁸Tokai University School of Medicine, Kanagawa, Japan
⁹University of Alberta, Edmonton, AB, CAN
¹⁰Roswell Park Cancer Institute, Buffalo, NY
¹¹Nagasaki University, Nagasaki, Japan
¹²Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, NC
¹³Department of Hematology and Oncology, University of Fukui, Fukui, Japan
¹⁴Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
¹⁵Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
¹⁶Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
¹⁷Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
¹⁸Sumitomo Pharma America, Inc., Marlborough, MA
¹⁹Duke Cancer Institute, Durham, NC

Jiajia Pan^1,2,3,4*, Huafeng Wang^1,2,3,4*, Liping Mao, MD^1,2,3,4*, Yinjun Lou, MD^1,2,3,4*, Yanling Ren, MD^1,2,3,4*, Xingnong Ye, MD^1,2,3,4*, Honghu Zhu, MD^1,2,3,4*, Min Yang, MD^1,2,3,4*, Jiejing Qian, MD^1,2,3,4* and Jie Jin^1,2,3,4

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China
³Zhejiang Provincial Key Lab of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China
⁴Zhejiang University Cancer Center, Hangzhou, China

Ewa Lech Marańda, Prof^1*, Elzbieta Patkowska^1*, Natalia Jakacka, MD^1*, Camille N. Abboud, MD², Howard A. Burris, MD³, Scott R. Solomon, MD⁴, Noemi Angelosanto, MD⁵, Tomasz Rzymski, PhD^5*, Peter Littlewood, PhD^5*, Kamil Kuś, PhD^5*, Agnieszka Sroka-Porada^5*, Renata Dudziak, MD^5*, Hendrik Nogai, MD^5*, Axel Glasmacher, MD⁶, Terrence Bradley, MD⁷, Gautam Borthakur, MD⁸, Elie Mouhayar, MD^9*, Paweł Steckiewicz, MD^10*, Sylwia Kościółek- Zgódka, MD^10*, Agata Szymańska, MD^11* and Jan Maciej Zaucha, Prof^12*

¹Institute of Hematology and Transfusion Medicine, Warszawa, Poland
²Washington University School of Medicine, Saint Louis, MO
³Sarah Cannon Research Institute, NASHVILLE, TN
⁴BMT Group of Georgia, Atlanta, GA
⁵Ryvu Therapeutics, Kraków, Poland
⁶The University Hospital Bonn, Bonn, Germany
⁷University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹MD Anderson Cancer Center, Houston, TX
¹⁰Holy Cross Cancer Center, Kielce, Poland
¹¹Medical University of Gdańsk, Gdańsk, Poland
¹²Department of Haematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland

Maria L Amaya, MD, PhD¹, Christine M. McMahon², Marc Schwartz, MD^1*, Jonathan A Gutman, MD³, Connor Sohalski^3*, Jennifer Tobin, PharmD^3*, Austin E Gillen, PhD^2*, Anagha Inguva Sheth, BSc³, Brett M Stevens, PhD, BS^3*, Clayton Smith, MD³, Craig T. Jordan, PhD² and Daniel A. Pollyea, MD^3*

¹Division of Hematology, University of Colorado, Aurora, CO
²University of Colorado School of Medicine, Aurora, CO
³University of Colorado, Aurora, CO

Mika Kontro^1*, Anthony Selwyn Stein, MD², Marja Pyörälä, MD, PhD^3*, Johanna Rimpiläinen, MD^4*, Timo Siitonen, MD, PhD^5*, Maija Hollmén, PhD^6*, Marie-Louise Fjaellskog, MD, PhD^7*, Inka Pawlitzky, PhD^8*, Amer M. Zeidan, MBBS, MHS⁹ and Naval Daver, MD¹⁰

¹Helsinki University Hospital and University of Helsinki, Helsinki, FIN
²City of Hope National Medical Center, Duarte, CA
³Department of Medicine, Kuopio University Hospital, Kuopio, Finland
⁴Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
⁵Cancer Center, Hematology, Oulu University Hospital, Oulu, Finland
⁶Faron Pharmaceuticals, Turku, Finland
⁷Faron Pharmaceuticals, Boston, MA
⁸Faron, Turku, Finland
⁹Department of Internal Medicine, Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT
¹⁰Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Jeffrey Lancet, MD¹, Farhad Ravandi, MD, MBBS², Pau Montesinos, PhD, MD^3*, Jacqueline C. Barrientos, MD⁴, Talha Badar, MD⁵, Adrián Alegre, MD, MPH^6*, Asad Bashey, MD, PhD⁷, Juan Miguel Bergua Burgues^8*, Lorenzo Brunetti, MD^9*, Emily K Curran, MD¹⁰, David C. Christian de Leeuw, MD, PhD^11*, Enrico Derenzini, MD^12*, Gerwin A. Huls, Prof.¹³, Jeroen J.W.M. Janssen, MD, PhD¹⁴, Deepa Jeyakumar, MD¹⁵, Mojca Jongen-Lavrencic, MD, PhD¹⁶, Ashwin Kishtagari, MBBS¹⁷, Maria-Victoria Mateos¹⁸, Daniel Morillo, MD^19*, Alessandro Rambaldi, M.D.²⁰, Aaron S. Rosenberg, MD²¹, Gary J. Schiller, MD²², Uzma Ahmed, MD, MS^23*, Alexandru Cacovean, MD²³, Stephan W. Morris, MD^23*, Courtney Follit, PhD²³, Brian Munneke, PhD^23*, Ganesh Waghmare, MD, MPH^23*, Clarissa Mandap, BSN^23*, Mona Vimal, MS^23*, Thomas Butler, MS, MBA^23* and Hetty E. Carraway, MD, MBA²⁴

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hospital Universitari i Politecnic la Fe, Valencia, Spain
⁴Mount Sinai Medical Center, Miami Beach, FL
⁵Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
⁶Hospital Universitario de La Princesa, Madrid, Spain
⁷BMT Group of Georgia, Atlanta, GA
⁸Hospital San Pedro de Alcántara, Cáceres, Spain
⁹Clinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
¹⁰Hematology/Oncology, University of Cincinnati, Cincinnati, OH
¹¹Department of Hematology,, Amsterdam University Medical Centers, Location VUmc,, Amsterdam, NLD
¹²Oncohematology Division, IEO European Institute of Oncology IRCCS, Milan, Italy
¹³University Medical Center, University Groningen, Groningen, Netherlands
¹⁴Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
¹⁵Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
¹⁶Erasmus University Medical Center, Rotterdam, Netherlands
¹⁷Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Franklin, TN
¹⁸University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
¹⁹Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
²⁰Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
²¹UC Davis Comprehensive Cancer Center, Sacramento, CA
²²Hematological Malignancy/ Stem Cell Transplant Program, David Geffen School of Medicine, UCLA, Los Angeles, CA
²³Biomea Fusion, Redwood City, CA
²⁴Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH

Sylvain Garciaz^1*, Amine Belhabri, MD^2*, Romain Guieze, MD, PhD^3*, Laure Goursaud, PhD^4*, Pierre Peterlin^5*, Marie-Pierre Ledoux^6*, Hunault-Berger Mathilde^7*, Safia Chebrek^8*, Jean-Baptiste Robin^9*, Arnaud Pigneux, MD, PhD^10*, Sarah Bonnet, MD^11*, Caroline Bonmati, MD^12*, Sarah Bertoli^13*, Thorsten Braun, MD, PhD¹⁴, Sylvain Chantepie, MD^15*, Mathieu Meunier, MD, PhD^16*, Mael Heiblig^17*, Thomas Cluzeau, MD, PhD¹⁸, Eric Jourdan, MD, PhD^19*, Alban Villate, MD^20*, Christian Recher, MD, PhD^21*, Norbert Vey, MD²² and Jerome Rey, MD^23*

¹Hematology Department, Integrative Structural and Chemical Biology, Aix-Marseille Université, Inserm, CNRS, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
²Centre Leon Berard, Lyon, FRA
³CHU Estaing, Clermont Ferrand, FRA
⁴CHU Lille, Lille, FRA
⁵Hematology Department, Hôpital Hotel Dieu, NANTES CEDEX 1, France
⁶CHU Strasbourg, Strasbourg Cedex 2, FRA
⁷Hematology Department, CHU Angers, Angers, France
⁸CH d'Avignon, Avignon, FRA
⁹CH Bayonne, Bayonne, France
¹⁰Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
¹¹Clinical Hematology Department, Montpellier University Hospital, Montpellier, France, montpellier, France
¹²Hematology Department, CHU Nancy, Nancy, France
¹³IUCT-Oncopole, Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹⁴Clinical Hematology, Avicenne University Hospital, Assistance Publique – Hôpitaux de Paris, Bobigny, France
¹⁵Institut d'Hématologie, CHU de Caen, Caen, France
¹⁶Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
¹⁷Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
¹⁸Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
¹⁹Hematology department, Institut de Cancérologie du Gard, CHU de Nîmes, Nimes, France
²⁰CHRU Bretonneau, Tours, FRA
²¹Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
²²Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France
²³Department of Hematology, Institut Paoli-Calmettes, Marseille, France

Paola Minetto, MD¹, Sara Rosellini^2*, Fabio Guolo, MD, PhD^3,4*, Elisabetta Tedone^4*, Ernesta Audisio, MD^5*, Chiara Cattaneo, MD⁶, Monica Bocchia, MD^7*, Nicola Fracchiolla, MD^8*, Maria Paola Martelli, MD, PhD^9*, Enrico Crea, PharmD^10*, Enrico Carminati, PhD^3*, Livia Gorreo Renzulli^10*, Giuseppina Fugazza^3*, Alfonso Piciocchi^10*, Giovanni Ottonelli^11*, Maurizio Miglino, MD, PhD^1,3*, Michele Cea^1,12*, Antonio Curti, MD, PhD¹³, Livio Pagano, MD^14*, Adriano Venditti, MD^15,16, Tariq Mughal, MD¹⁷ and Roberto Massimo Lemoli, MD^1,3*

¹Clinica Ematologica, Dipartimento di Oncologia e Ematologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
²Servizio di Citofluorimetria, Dipartimento di Anatomia Patologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
³Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
⁴IRCCS Ospedale Policlinico San Martino, Genoa, Italy
⁵SC Ematologia 2, AOU Città della Salute e della Scienza, Turin, Italy
⁶Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
⁷UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
⁸Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
⁹Hematology, Department of Surgery and Medicine, University of Perugia and ‘Santa Maria della Misericordia’ Hospital, Perugia, Italy
¹⁰GIMEMA Foundation, Rome, Italy
¹¹University of Genoa, Genoa, Italy
¹²Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genova, Italy
¹³IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
¹⁴Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy
¹⁵Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁶Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy, Italy
¹⁷Department of Hematology/Oncology, City of Hope, Duarte, CA

Jae-Seon Lee, PhD^1*, Min Ji Park, PhD^2*, Ningning Sun, PhD^2*, Jin-Hee Park, PhD^2*, Su-jin Oh, MS^2*, Miran Moon, MS^2*, Myung Jin Kim, PhD^2*, Soo Yeon Jang, MS^2* and Yong-Chul Kim, PhD^2*

¹PeLeMed, Seoul, AL, South Korea
²PeLeMed, Seoul, Korea, Republic of (South)

Xia Jiang^1*, Haihui Zhuang^2*, Fenglin Li, MD^3*, Lei Jiang^4*, Jie Jin⁵ and Ying Lu^6*

¹Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
²Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo, China
³Department of Hematology, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhengjiang, CHN
⁴The Affiliated People's Hospital of Ningbo University, Ningbo, Chile
⁵Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶Department of Hematology, Yinzhou People's Hospital, Ningbo, China

Thomas Pabst, MD¹, Mojca Jongen-Lavrencic, MD, PhD², Steffen Boettcher, MD^3*, Gerwin A. Huls, Prof.⁴, David C. de Leeuw, MD, PhD^5*, Philippe Legenne^6*, Mariola Dymkowska^6*, Christiane Andrieu^6*, Oliver Schönborn-Kellenberger^7*, Paul G. Baverel^6*, Zita Arany^6*, Elena Fernandez^6*, Anne Goubier^6*, Vladimir Kirkin^6*, Nicolas Leupin^6* and Marion Subklewe, MD⁸

¹Department of Medical Oncology, Bern University Hospital, Bern, Switzerland
²Erasmus University Medical Center, Rotterdam, Netherlands
³University of Zurich and University Hospital, Zurich, Switzerland
⁴Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
⁵Amsterdam University Medical Center, Amsterdam, Netherlands
⁶Molecular Partners AG, Zurich-Schlieren, Switzerland
⁷Cogitars GmbH, Heidelberg, Germany
⁸University Hospital Munich, Munich, Germany

Emmanuel Almanza Huante, MD, MDN^1*, Alex Bataller, MD, PhD^2*, Danielle E. Hammond, MD², Kelly S. Chien, MD², Courtney D. DiNardo, MD, MSc², Nicholas J. Short, MD², Abhishek Maiti, MD², Guillermo Montalban-Bravo, MD², Farhad Ravandi, MD, MBBS², Guillermo Garcia-Manero, MD³ and Tapan M. Kadia, MD²

¹The university of Texas. MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Houston, TX

Marie Anne Hospital, MD, PhD^1*, Thomas Cluzeau, MD, PhD², Alice Garnier, MD^3*, Giovanni Marconi, MD⁴, Emmanuelle Tavernier, MD^5*, Sylvain Thepot, MD^6*, Aspasia Stamatoullas, MD^7*, Cristina Papayannidis, MD⁸, Sophie Park, MD, PhD⁹, Noemie Bigot^10*, Lamya AIT SI Selmi^11*, Fatiha Chermat^12*, Sylvie Chevret, MD, PhD^13* and Pierre Fenaux, MD, PhD¹⁴

¹Hematology Department, Institut Paoli Calmettes, MARSEILLE, France
²Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
³Hematology clinic, Nantes University Hospital, Nantes, France
⁴IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST S.r.l, Meldola, Italy
⁵Institut De Cancérologie De La Loire, Saint Priest En Jarez, FRA
⁶Department of Clinical Hematology, Angers University Hospital, ANGERS, NA, France
⁷Centre Henri Becquerel, Rouen, France, Rouen, FRA
⁸Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
⁹Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
¹⁰Biostatistics Department, Hôpital Saint Louis, APHP, Paris, France
¹¹Groupe francophone des myélodysplasies, PARIS, France
¹²Groupe Francophone des Myelodysplasies, Paris, France
¹³Hôpital Saint Louis, APHP, Paris, FRA
¹⁴Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France

Eric S. Winer, MD¹, Amit Verma, MD², Stefanie Groepper, MD^3*, Katharina S. S. Götze, MD⁴, Yasmin Abaza, MD⁵, Christoph Schliemann, MD^6*, Gaurav S Choudhary, PhD^7*, Wanying Zhao, PhD^7*, Cole Gallagher, BS^7*, Reinhard von Roemeling, MD⁷ and Daniel J. DeAngelo¹

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
³Marien Hospital, University of Düsseldorf, Düsseldorf, Germany
⁴Department of Medicine III, Hematology and Oncology, Technical University of Munich School of Medicine, Munich, Germany
⁵Northwestern Medicine, Chicago, IL
⁶Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
⁷Curis Inc., Lexington, MA

Huafeng Wang^1*, Xudong Wei^2*, Qian Jiang, MD³, Wenjun He^4*, Qiubai Li^4*, Yang Liang, MD, PhD⁵, Jianyu Weng, M.D., Ph.D.^6*, Suning Chen, MD^7*, Hongbing Ma^8*, Chukang Chang^9*, Yajing Xu, MD^10*, Qun He^10*, Zi Chen^11*, Lihui Liu^11*, Lichuang Men^11*, Danhua Cong^11*, Zhang Zhang^12*, Dajun Yang^13,14*, Yifan Zhai^14,15 and Jie Jin IV^16*

¹The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
²Henan Cancer Hospital, Zhengzhou, China
³Peking University People’s Hospital, Beijing, China
⁴Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Sun Yat-sen University Cancer Center, Guangzhou, China
⁶Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
⁷The First Affiliated Hospital of Soochow University, Suzhou, China
⁸West China Hospital, Sichuan University, Chengdu, China
⁹Shanghai Sixth People’s Hospital, Shanghai, China
¹⁰Xiangya Hospital of Central South University, Changsha, China
¹¹Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
¹²Ascentage Pharma Group, Inc., Rockville, MD
¹³Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
¹⁴Ascentage Pharma Group Inc., Rockville, MD
¹⁵State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
¹⁶The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China